Metraipolis › archive › dc_f5a4d79fea2f

Atorvastatin as an immunomodulatory adjunct in ulcerative colitis, beyond lipid lowering to inflammation control: a randomized controlled pilot study — Europe PMC PMID:41235106

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41235106
DOI
10.3389/fphar.2025.1690513
License (as archived)
solo-consultazione
Archived
2026-11-08T23:44:06.055Z
SHA-256 of the archived text
a69313e82c2b77196704199aa2d5cbff200a4008f31bdbebaa8f379e606d2b64
Stable URL of this page
https://metraipolis.com/documento/dc_f5a4d79fea2f

How to cite

Atorvastatin as an immunomodulatory adjunct in ulcerative colitis, beyond lipid lowering to inflammation control: a randomized controlled pilot study — Europe PMC PMID:41235106 — Europe PMC (en), https://europepmc.org/article/MED/41235106 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f5a4d79fea2f (Metraipolis archive dc_f5a4d79fea2f, sha256 a69313e82c2b77196704199aa2d5cbff200a4008f31bdbebaa8f379e606d2b64)
BibTeX
@misc{dcf5a4d79fea2f,
  title = {Atorvastatin as an immunomodulatory adjunct in ulcerative colitis, beyond lipid lowering to inflammation control: a randomized controlled pilot study — Europe PMC PMID:41235106},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41235106},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f5a4d79fea2f; sha256 a69313e82c2b77196704199aa2d5cbff200a4008f31bdbebaa8f379e606d2b64},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41235106. Agents can read the archived copy with the MCP tool read_document.